Expert Analysis

FDA's Multifaceted Role On Display In MDMA Therapy Scrutiny

Ongoing deliberations at the U.S. Food and Drug Administration regarding MDMA-assisted therapy for post-traumatic ... (more story)

Analyzing FDA Draft Guidance On Clinical Trial Diversity

In light of the U.S. Food and Drug Administration's draft guidance on clinical trial diversity action plans, there... (more story)

What's New In The AI Healthcare Regulatory Space

Attorneys at Hogan Lovells review the current legal and regulatory landscape for artificial intelligence applicati... (more story)

Deals & Corporate Governance More

Healthcare Dealmaking Trends Of 2024: A Midyear Review

While each deal is unique, transactions don't occur in a vacuum. Here, Law360 Healthcare Authority reviews five trends that helped shape some of those deals and the wider healthcare industry so far this year.

Takeaways From This Week's Healthcare Earnings

This past week, healthcare companies Johnson & Johnson, Elevance Health and Novartis announced results for the second quarter of the calendar year, kicking off the earnings season. Here are the two big takeaways.

FTC Tells 5th Circ. Anesthesia Co. Can't Stop Antitrust Case

The Federal Trade Commission is telling the Fifth Circuit to dismiss U.S. Anesthesia Partners Inc.'s appeal in the FTC's antitrust case against it, saying the circuit court has no jurisdiction in the appeal be... (more story)

NC AG Looks To Stave Off Deposition In Hospital Contract Suit

North Carolina Attorney General Josh Stein doesn't want to be deposed in his suit accusing a for-profit health network of breaking its promise to maintain the standard of care at an Asheville hospital, saying ... (more story)

Kirkland, MoFo Steer $139M Take-Private Of Medtech Biz

Augmedix Inc., advised by Morrison Foerster LLP, on Friday announced its plans to go private following its sale to fellow healthcare technology company Commure Inc., advised by Kirkland & Ellis LLP, in a deal ... (more story)

Ocugen Execs Hit With Derivative Suit Over Shoddy Controls

The top brass at biopharmaceutical company Ocugen Inc. were hit with a derivative suit alleging the company's lack of effective internal financial controls caused it to be misvalued and allowed shareholders to... (more story)

Digital Health & Technology More

Texas Legal Services Biz Escapes Most Data Breach Claims

A Texas federal judge has trimmed most claims in a proposed class action over a legal services company's data breach, leaving a negligence claim lodged by one plaintiff who alleges he was a victim of identity ... (more story)

Clinic Gets NC Biz Court's Final OK For Hacking Suit Deal

A North Carolina Business Court judge granted final approval to a class action settlement between a physician-owned orthopedic practice and the current and former patients who took it to court over a data brea... (more story)

NC Hospital, Patients Nearing Deal In Hacking Suit

Columbus Regional Healthcare System and the patients who accused it of failing to properly protect their personal information at its North Carolina hospital have reached a tentative settlement agreement, accor... (more story)

Teladoc Hit With Another Investor Suit Over BetterHelp Woes

The telehealth company that owns online counseling platform BetterHelp has been slapped with a second investor suit accusing it of not being honest with investors about how profitable the mental health service actually was.

3 Policyholder Tips After Calif. Ruling Denying D&O Coverage

A California decision from June, Practice Fusion v. Freedom Specialty Insurance, denying a company's claim seeking reimbursement under a directors and officers insurance policy for its settlement with the Just... (more story)

How Tech Trackers May Implicate HIPAA After Hospital Ruling

A recent Texas federal court order in American Hospital Association v. Becerra adds a legal protection on key data, clarifying when tracking technologies implicate the Health Insurance Portability and Accounta... (more story)

Policy & Compliance More

Meet The Lead Ozempic Lawyers

The recently deceased U.S. District Judge Gene E.K. Pratter this past spring appointed plaintiff leadership in litigation over Ozempic and similar drugs over allegations that the medications cause gastrointest... (more story)

Kickback Risk Remains For Gene Therapy Fertility Programs

Federal health officials this week declined to relieve two companies of potential liability under the Anti-Kickback Statute concerning their fertility support programs for patients receiving gene therapies.

Wash. AG Says 'Abortion Reversal' Clinic's Suit Still Deficient

Washington state's attorney general said Monday an anti-abortion clinic group being investigated for marketing an "abortion reversal pill" cannot blame his two-year-old document demands for a recent insurance ... (more story)

$680M Allergan FCA Suit Tossed After High Court Revival

A Maryland federal judge on Tuesday again tossed a False Claims Act suit accusing an Allergan unit of overcharging Medicaid, previously revived by the U.S. Supreme Court, saying a whistleblower still hadn't sh... (more story)

6th Circ. Vows Careful Immunity Take In Prof's Retaliation Suit

The Sixth Circuit wrestled Tuesday with whether six University of Louisville officials were each rightly denied immunity from a former professor's suit alleging he was unconstitutionally pushed out because of ... (more story)

On Capitol Hill, PBM Execs Deny Role In High Drug Costs

Executives from the nation's three largest pharmacy benefit managers told members of a U.S. House committee on Tuesday that they lower drug costs while pointing the finger at pharmaceutical manufacturers.